APA

Pratz K. W., Rudek M. A., Gojo I., Litzow M. R., McDevitt M. A., Ji J., Karnitz L. M., Herman J. G., Kinders R. J., Smith B. D., Gore S. D., Carraway H. E., Showel M. M., Gladstone D. E., Levis M. J., Tsai H., Rosner G., Chen A., Kaufmann S. H. & Karp J. E. (20180213). A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Pratz Keith W, Rudek Michelle A, Gojo Ivana, Litzow Mark R, McDevitt Michael A, Ji Jiuping, Karnitz Larry M, Herman James G, Kinders Robert J, Smith B Douglas, Gore Steven D, Carraway Hetty E, Showel Margaret M, Gladstone Douglas E, Levis Mark J, Tsai Hua-Ling, Rosner Gary, Chen Alice, Kaufmann Scott H and Karp Judith E. 20180213. A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Pratz K. W., Rudek M. A., Gojo I., Litzow M. R., McDevitt M. A., Ji J., Karnitz L. M., Herman J. G., Kinders R. J., Smith B. D., Gore S. D., Carraway H. E., Showel M. M., Gladstone D. E., Levis M. J., Tsai H., Rosner G., Chen A., Kaufmann S. H. and Karp J. E. (20180213). A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Pratz Keith W, Rudek Michelle A, Gojo Ivana, Litzow Mark R, McDevitt Michael A, Ji Jiuping, Karnitz Larry M, Herman James G, Kinders Robert J, Smith B Douglas, Gore Steven D, Carraway Hetty E, Showel Margaret M, Gladstone Douglas E, Levis Mark J, Tsai Hua-Ling, Rosner Gary, Chen Alice, Kaufmann Scott H and Karp Judith E. A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20180213.